Scientists have developed a new DNA origami–based vaccine platform called DoriVac that could rival mRNA vaccines while being easier to manufacture and store. Early studies show it can trigger strong immune responses against viruses like SARS-CoV-2, HIV, and Ebola. The COVID-19 pandemic pushed messenger RNA (mRNA) vaccines into the spotlight of global health. After completing […]
Source link